TITLE

Half of patients cannot use their adrenaline injectors

AUTHOR(S)
Kelly, Brian
PUB. DATE
July 2002
SOURCE
Pulse;7/22/2002, Vol. 62 Issue 29, p7
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Discusses a study which revealed that more than half of the patients with life-threatening allergies do not know how to use their adrenaline devices in Great Britain. Role of general practitioners in inappropriately prescribing adrenaline in non life-threatening cases; Remarks from Doctor Gavin Spickett on prescribing adrenaline for non life-threatening events; Criticism against the government over failure to recognize allergy as an area needing investment.
ACCESSION #
7081830

 

Related Articles

  • Economic considerations in the treatment of systemic allergic reactions. Westermann-Clark, Emma; Pepper, Amber N; Lockey, Richard F // Journal of Asthma & Allergy;Jun2018, Vol. 11, p153 

    Epinephrine is a life-saving medication used to treat systemic allergic reactions including anaphylaxis. Epinephrine autoinjectors (EAIs) are expensive and worldwide availability is limited. Epinephrine prefilled syringes and epinephrine kits are potentially lower-cost alternatives to EAIs....

  • Epinephrine Injection.  // AHFS Consumer Medication Information;Sep2020, p1 

    Epinephrine injection is used to treat life-threatening allergic reactions caused by insect bites, foods, medications, latex, and other causes. Symptoms of allergic reaction include wheezing, shortness of breath, low blood pressure, hives, itching, swelling, stomach cramps, diarrhea, and loss of...

  • Generic Version of EpiPen Said to Encounter Delay.  // Chain Drug Review;10/24/2016, Vol. 38 Issue 16, p80 

    The article reports on the delay of the release of the EpiPen allergy shot manufactured by pharmaceutical company Mylan NV.

  • 'GPs should lead allergy services'  // Pulse;6/30/2003, Vol. 63 Issue 26, p7 

    Reports on the need for a massive training program for general practitioners in the treatment of allergies in Great Britain.

  • Allergy treatment is falling to GPs. Dragon, Natalie // GP: General Practitioner;6/30/2003, p13 

    GPs are bearing the brunt of caring for patients with allergies because of inadequate services and a lack of specialists, according to a report from the Royal College of Physicians (RCP). Shortages of specialists mean patients with allergies are treated almost exclusively by GPs who, in most...

  • Insulin-lispro: Allergic reaction at cannula insertion site: case report.  // Reactions Weekly;Jun2019, Vol. 1756 Issue 1, p194 

    The article presents a case study of a 28-year-old woman having allergic reaction at the cannula insertion site after being treated with insulin lispro for type 1 diabetes mellitus.

  • EpiPen Woes Drive Third-Quarter Mylan Losses. ROSS, JIM // State Journal (WV);11/18/2016, Vol. 32 Issue 46, p19 

    No abstract available.

  • Systemic Anaphylaxis and Inhaled Epinephrine. Huffman, Grace Brooke // American Family Physician;5/15/2001, Vol. 63 Issue 10, p2034 

    Presents an abstract of the study `Can Epinephrine Inhalations Be Substituted for Epinephrine Injection in Children at Risk for Systemic Anaphylaxis?' by F.E. Simons et al., from the November 5, 2000 issue of `Pediatrics.'

  • Sesame allergy: current perspectives. Adatia, Adil; Clarke, Ann Elaine; Yanishevsky, Yarden; Ben-Shoshan, Moshe // Journal of Asthma & Allergy;Apr2017, Vol. 10, p141 

    Sesame is an important global allergen affecting ~0.1% of the North American population. It is a major cause of anaphylaxis in the Middle East and is the third most common food allergen in Israel. We conducted a systematic review of original articles published in the last 10 years regarding the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics